SCI.NS(SCI.NS)
SCI.NS
No analyst ratings available
No analyst price targets available for SCI.NS
Analyst coverage may not be available for this symbol
No recent analyst actions
| Metric | FY2027E | FY2028E | FY2029E | FY2030E | FY2031E |
|---|---|---|---|---|---|
| Revenue Avg | $34.76B | $32.86B | $35.81B | $41.49B | $37.60B |
| Low | $34.76B | $32.86B | $35.81B | $41.49B | $37.60B |
| High | $34.76B | $32.86B | $35.81B | $41.49B | $37.60B |
| EBITDA Avg | $20.42B | $19.30B | $21.03B | $24.37B | $22.09B |
| Low | $20.42B | $19.30B | $21.03B | $24.37B | $22.09B |
| High | $20.42B | $19.30B | $21.03B | $24.37B | $22.09B |
| EBIT Avg | $12.40B | $11.72B | $12.77B | $14.79B | $13.41B |
| Low | $12.40B | $11.72B | $12.77B | $14.79B | $13.41B |
| High | $12.40B | $11.72B | $12.77B | $14.79B | $13.41B |
| Net Income Avg | $2.71B | $-570M | $342M | $2.22B | $142M |
| Low | $2.71B | $-570M | $342M | $2.22B | $142M |
| High | $2.71B | $-570M | $342M | $2.22B | $142M |
| EPS Avg | $5.81 | $-1.22 | $0.73 | $4.77 | $0.31 |
| Low | $5.81 | $-1.22 | $0.73 | $4.77 | $0.31 |
| High | $5.81 | $-1.22 | $0.73 | $4.77 | $0.31 |
| Analysts (Rev / EPS) | 1 / 1 | 1 / 1 | 1 / 1 | 1 / 1 | 1 / 1 |